Literature DB >> 9371600

Mutational analysis of the hepatitis C virus RNA helicase.

D W Kim1, J Kim, Y Gwack, J H Han, J Choe.   

Abstract

The carboxyl-terminal three-fourths of the hepatitis C virus (HCV) NS3 protein has been shown to possess an RNA helicase activity, typical of members of the DEAD box family of RNA helicases. In addition, the NS3 protein contains four amino acid motifs conserved in DEAD box proteins. In order to inspect the roles of individual amino acid residues in the four conserved motifs (AXXXXGKS, DECH, TAT, and QRRGRTGR) of the NS3 protein, mutational analysis was used in this study. Thirteen mutant proteins were constructed, and their biochemical activities were examined. Lys1235 in the AXXXXGKS motif was important for basal nucleoside triphosphatase (NTPase) activity in the absence of polynucleotide cofactor. A serine in the X position of the DEXH motif disrupted the NTPase and RNA helicase activities. Alanine substitution at His1318 of the DEXH motif made the protein possess high NTPase activity. In addition, we now report inhibition of NTPase activity of NS3 by polynucleotide cofactor. Gln1486 was indispensable for the enzyme activity, and this residue represents a distinguishing feature between DEAD box and DEXH proteins. There are four Arg residues in the QRRGRTGR motif of the HCV NS3 protein, and the second, Arg1488, was important for RNA binding and enzyme activity, even though it is less well conserved than other Arg residues. Arg1490 and Arg1493 were essential for the enzymatic activity. As the various enzymatic activities were altered by mutation, the enzyme characteristics were also changed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371600      PMCID: PMC230244     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Birth of the D-E-A-D box.

Authors:  P Linder; P F Lasko; M Ashburner; P Leroy; P J Nielsen; K Nishi; J Schnier; P P Slonimski
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

3.  RNA unwinding activity of SV40 large T antigen.

Authors:  M Scheffner; R Knippers; H Stahl
Journal:  Cell       Date:  1989-06-16       Impact factor: 41.582

4.  Sequences of the E. coli uvrB gene and protein.

Authors:  E Arikan; M S Kulkarni; D C Thomas; A Sancar
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

5.  The QRxGRxGRxxxG motif of the vaccinia virus DExH box RNA helicase NPH-II is required for ATP hydrolysis and RNA unwinding but not for RNA binding.

Authors:  C H Gross; S Shuman
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Vaccinia virus RNA helicase: an essential enzyme related to the DE-H family of RNA-dependent NTPases.

Authors:  S Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.

Authors:  E A Brown; H Zhang; L H Ping; S M Lemon
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Mutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor eIF-4A.

Authors:  A Pause; N Sonenberg
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

10.  Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.

Authors:  J E Walker; M Saraste; M J Runswick; N J Gay
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  48 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase.

Authors:  Y L Khu; E Koh; S P Lim; Y H Tan; S Brenner; S G Lim; W J Hong; P Y Goh
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  RNA helicase dynamics in pre-mRNA splicing.

Authors:  B Schwer; T Meszaros
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

4.  Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.

Authors:  A E Matusan; M J Pryor; A D Davidson; P J Wright
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  ATP-dependent remodeling of the spliceosome: intragenic suppressors of release-defective mutants of Saccharomyces cerevisiae Prp22.

Authors:  Eva Campodonico; Beate Schwer
Journal:  Genetics       Date:  2002-02       Impact factor: 4.562

6.  Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey.

Authors:  Esra Yildiz; Asli Oztan; Funda Sar; Ergun Pinarbasi; Rengul Cetin-Atalay; Hikmet Akkiz; Mehmet Ozturk
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

7.  Structure-based mutational analysis of the NS3 helicase from dengue virus.

Authors:  Aruna Sampath; Ting Xu; Alex Chao; Dahai Luo; Julien Lescar; Subhash G Vasudevan
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.

Authors:  Dong-chul Kang; Rahul V Gopalkrishnan; Qingping Wu; Eckhard Jankowsky; Anna Marie Pyle; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

9.  Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.

Authors:  Silvana Gaudieri; Andri Rauch; Lawrence P Park; Elizabeth Freitas; Susan Herrmann; Gary Jeffrey; Wendy Cheng; Katja Pfafferott; Kiloshni Naidoo; Russell Chapman; Manuel Battegay; Rainer Weber; Amalio Telenti; Hansjakob Furrer; Ian James; Michaela Lucas; Simon A Mallal
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

10.  Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

Authors:  Byounghoon Hwang; Jung Sun Cho; Hyeon Ju Yeo; Jung-Hye Kim; Kyung Min Chung; Kyungsook Han; Sung Key Jang; Seong-Wook Lee
Journal:  RNA       Date:  2004-07-09       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.